Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-17

Clinical Trial Update: Isotretinoin in Papular-Pustular Rosacea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating isotretinoin for papular-pustular rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Laboratoires Bailleul-Biorga | Conditions: Papular-pustular Rosacea | Phase 3 | Status: COMPLETED